Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. XOLAIR
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
  • Date 04 January 2006
  • Documents : 3
  • History
Download opinion
Listen Listen
Add to my selection
    Quote this publication
    Share
    Share on
    Facebook share - facebook.com - new window
    Tweeter share - Partager sur Twitter - twitter.com - new window
    LinkedIn share - linkedin.com - new window
    Print

    XOLAIR

    Opinions on drugs - Posted on Jan 24 2013

    Reason for request

    inclusion on list of drugs reimbursed by social security and for hospital use

    Documents

    • XOLAIR - CT-2170 Xvox
    • XOLAIR FIT 05092012 Xvox

    English version

    • XOLAIR - CT-2170 - English version Xvox

    Contact Us

    Évaluation des médicaments
    • Contact Us
    All our publications
      Bronchial diseases Drug therapy Paediatrics Pulmonary and pleural diseases

    Follow us :

    • Twitter (nouvelle fenêtre)
    • Facebook (nouvelle fenêtre)
    • Youtube (nouvelle fenêtre)
    • LinkedIn (nouvelle fenêtre)
    Haute Autorité de Santé
    Advancing quality in the fields of health and social care services
    • Eunetha.eu
    • Pasq.eu
    • All our publications by topic and type
    • Opinions on medicines
    • Opinions on medical devices
    • INAHTA briefs
    • Français
    • English
    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
    7Aytc5pv7NhK30D2